col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


24 Ergebisse       Seite 1

 [1] 
Elsevier: International Journal of Pharmaceutics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mrz―16 Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2 Alberto Baldelli, Chun Yuen Jerry Wong, Hale Oguzlu, Hanieh Gholizadeh, Yigong Guo, Hui Xin Ong, et al. (+3)
2 [GO] 2024―Feb―29 Mannosylated polyethylenimine-cholesterol-based nanoparticles for targeted delivery of minicircle DNA vaccine against COVID-19 to antigen-presenting cells Dalinda Eusébio, Milan Paul, Swati Biswas, Zhengrong Cui, Diana Costa, Ângela Sousa.
3 [GO] 2023―Aug―15 Assessing the physicochemical stability and intracellular trafficking of mRNA-based COVID-19 vaccines Benedetta Fongaro, Benedetta Campara, Giulia Yuri Moscatiello, Ada De Luigi, Davide Panzeri, Laura Sironi, et al. (+5)
4 [GO] 2023―Jul―02 Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles Ji Wang, Yanhao Zhang, Shuo Dong, Wenhui Zha, Chao Liu, Yang Wang, et al. (+3)
5 [GO] 2023―Mai―13 Aqueous cannabidiol β-cyclodextrin complexed polymeric micelle nasal spray to attenuate in vitro and ex-vivo SARS-CoV-2-induced cytokine storms Narumon Changsan, Somchai Sawatdee, Roongnapa S, Charisopon Chunhachaichana, Teerapol Srichana
6 [GO] 2023―Apr―05 Functionalized protein microparticles targeting hACE2 as a novel preventive strategy for SARS-CoV-2 infection Yujia Li, Yike Huang, Kehui Zhu, Xiaoqiong Duan, Shilin Li, Min Xu, et al. (+8)
7 [GO] 2023―Mrz―01 Cuprous oxide nanoparticles incorporated into a polymeric matrix embedded in fabrics to prevent spread of SARS-CoV-2 Nadina Usseglio, Renée Onnainty, Brenda Konigheim, Javier Aguilar, Juan Pablo Petiti, Giuliana Lingua, et al. (+4)
8 [GO] 2022―Nov―19 Recent updates on liposomal formulations for detection, prevention and treatment of coronavirus disease (COVID-19) Nur Dini Fatini Mohammad Faizal, Mohd Cairul Iqbal Mohd Amin
9 [GO] 2022―Okt―02 An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization Fu-Fei Hsu, Kang-Hao Liang, Monika Kumari, Wan-Yu Chen, Hsiu-Ting Lin, Chao-Min Cheng, et al. (+2)
10 [GO] 2022―Jul―20 Inhaled Therapy for COVID-19: Considerations of Drugs, Formulations and Devices Tushar Saha, Miguel E. Quiñones-Mateu, Shyamal C. Das
11 [GO] 2022―Mrz―19 Pharmacokinetics and Safety of Inhaled Ivermectin in Mice as a Potential COVID-19 Treatment Ahmed H. Albariqi, Yuncheng Wang, Rachel Yoon Kyung Chang, Diana H. Quan, Xiaonan Wang, Stefanie Kalfas, et al. (+3)
12 [GO] 2021―Okt―22 Innovative vaccine platforms against infectious diseases: under the scope of the COVID-19 pandemic Maria Tsakiri, Nikolaos Naziris, Costas Demetzos
13 [GO] 2021―Sep―23 Targeted pulmonary drug delivery in coronavirus disease (COVID-19) therapy: A patient-specific in silico study based on magnetic nanoparticles-coated microcarriers adhesion Sina Ebrahimi, Amir Shamloo, Mojgan Alishiri, Yasaman Mozhdehbakhsh Mofrad, Fatemeh Akherati
14 [GO] 2021―Sep―21 Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection Md Abdur Rashid, Saiqa Muneer, Jayanti Mendhi, Mohammad Zaidur Rahman Sabuj, Yahya Alhamhoom, Yin Xiao, et al. (+3)
15 [GO] 2021―Aug―18 Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19 Hui-Min Ho, Chiung-Yi Huang, Yu-Jhen Cheng, Kuan-Yin Shen, Tsai-Teng Tzeng, Shih-Jen Liu, et al. (+3)
16 [GO] 2021―Aug―18 Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection Shaymaa Elsayed Khate, Ahmed El-khouly, Hend Mohamed Abdel-Ba, Abdulaziz Mohsen Al-mahallawi, Dalia Mahmoud Ghorab
17 [GO] 2021―Jun―23 Continuous Manufacture of Hydroxychloroquine Sulfate Drug Products via Hot Melt Extrusion Technology to Meet Increased Demand During a Global Pandemic: From Bench to Pilot Scale Victoire de Margerie, Christopher McConville, Suha M. Dadou, Shu Li, Pascal Boulet, Lionel Aranda, et al. (+5)
18 [GO] 2021―Mai―06 Nasal vaccination against SARS-CoV-2: synergistic or alternative to intramuscular vaccines? Mattia Tiboni, Luca Casettari, Lisbeth Illum
19 [GO] 2021―Apr―15 Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation Soad A. Mohamad, Ahmed M. Badawi, Heba F. Mansour
20 [GO] 2021―Apr―09 mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, Rein Verbeke, Gideon Kersten, Wim Jiskoot, Daan Crommelin
21 [GO] 2021―Feb―03 Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment Manali Patki, Siddhant Palekar, Sandra Reznik, Ketan Patel
22 [GO] 2020―Nov―07 Optimization and Evaluation of Propolis liposomes as a promising therapeutic approach for COVID-19 Hesham refaat, Fatma M. Mady, Hatem A. Sarhan, Heba S. Rateb, Eman Alaaeldin
23 [GO] 2020―Jul―25 The Lord of the NanoRings: cyclodextrins and the battle against SARS-CoV-2 Pablo F. Garrido, Martín Calvelo, Alexandre Blanco-González, Uxía Veleiro, Fabián Suárez, Daniel Conde, et al. (+3)
24 [GO] 2020―Mai―16 Hand sanitisers amid CoViD-19: A critical review of alcohol-based products on the market and formulation approaches to respond to increasing demand Alberto Berardi, Diego R. Perinelli, Hamid A. Merchant, Lorina Bisharat, Iman A. Basheti, Giulia Bonacucina, et al. (+2)
 [1] 

24 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec